Depression and suicidality;Depression und suizidalität

Verhaltenstherapie

Volumn 15, Issue 1, 2005, Pages 6-11

  Hegerl, Ulrich ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Antidepressants; Community based intervention; Depression; Prevention, suicide; Suicide

Indexed keywords

ANTIDEPRESSANT AGENT; SEROTONIN UPTAKE INHIBITOR;

CAREGIVER; DECISION MAKING; DEPRESSION; HUMAN; MEDICAL CARE; MENTAL DISEASE; PUBLIC RELATIONS; REVIEW; SUICIDE; SUICIDE ATTEMPT;

EID: 24044457308     PISSN: 10166262     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083697     Document Type: Review

References (29)

1. Althaus D, Stefanek J, Hasford J, Hegerl U: Wissensstand und Einstellungen der Allgemeinbevölkerung zu Symptomen, Ursachen und Behandlungsmöglichkeiten depressiver Erkrankungen. Nervenarzt 2002;73: 659-664.
2. Angst F, Stassen HH, Clayton PJ, Angst J: Mortality of patients with mood disorders: Follow-up over 34-38 years. J Affect Disord 2002;68:167-181.
3. Angst J: Consensus discussion. J Clin Psychiatry 1999; 60:113-116.
4. Black DW, Winokur G, Mohandoss E, Woolson RF, Nasrallah A: Does treatment influence mortality in depressives? A follow-up of 1,076 patients with major affective disorders. Ann Clin Psychiatry 1989;1:165-173.
5. Blair-West GW, Cantor CH, Mellsop GW, Eyeson-Annan ML: Lifetime suicide risk in major depression: Sex and age determinants. J Affect Disord 1999;55:171-178.
6. Brent DA, Perper J, Moritz G, Allmann C, Friend A, Roth C, Schweers J, Balach L, Baugher M: Psychiatric risk factors for adolescent suicide: A case-control study. J Am Acad Child Adolesc Psychiatry 1993;32:521-529.
7. Cheng AT: Mental illness and suicide - a case-control study in East Taiwan. Arch Gen Psychiatry 1995;52: 594-603.
8. Clayton PJ: Epidemiologic and risk factors for suicide; in Grinspoon L (ed): Psychiatry Update. Washington, DC, American Psychiatric Press, 1983, pp 428-434.
9. Fergusson D, Doucette S, Cranley Glass K, Shapiro S, Healy D, Hebert P Hutton B: Association between suicide attempts and selective serotonin reuptake inhibitors: Systematic review of randomised controlled trials. BMJ 2005;330:396.
10. Gunnell D, Ashby D: Antidepressants and suicide: What is the balance of benefit and harm? BMJ 2004;329:34-38.
11. Guze SB, Robins E: Suicide and primari affective disorder. Br J Psychiatry 1970;117:437-438.
12. Hall WD, Mant A, Mitchell PB, Rendle VA, Hickie IB, McManus P: Association between antidepressant prescribing and suicide in Australia, 1991-2000: Trend analysis. BMJ 2003;326:1008.
13. Hegerl U: Antidepressiva und Suizidalität. Verhaltenstherapie 2004;14:218-219.
14. Hegerl U, Althaus D, Stefanek J: Public attitudes towards treatment of depression: Effects of an information campaign. Pharmacopsychiatry 2003;36:288-291.
15. Henkel V, Mergl R, Kohnen R, Maier W, Moeller H, Hegerl U: Identifying depression in primary care: A comparison of different methods. BMJ 2003;226:200-221.
16. Inskip HM, Harris EC, Barraclough B: Lifetime risk of suicide for affective disorder, alcoholism and schizophrenia. Br J Psychiatry 1998;172:35-37.
17. Isacsson G, Holmgren P, Ahlner J: Do SSRIs induce suicide? A controlled study of Swedish suicides 1992-2000. Presented at the 17th ECNP 2004 in Stockholm.
18. Jureidini JN, Doecke CJ, Mansfield PR, Haby MM, Menkes DB, Tonkin AL: Efficacy and safety of anti-depressants for children and adolescents. BMJ 2004;328:879-883
19. Khan A, Khan S, Kolts R, Brown WA: Suicide rates in clinical trials of SSRIs, other antidepressants, and placebo: Analysis of FDA reports. Am J Psychiatry 2003;160:790-792.
20. Lönnqvist J: Psychiatric aspects of suicidal behaviour: Depression; in Hawton K, van Heeringen K (eds): The International Handbook of Suicide and Attempted Suicide. Chichester, John Wiley & Sons, 2000.
21. Morgan HG, Jones EM, Owen JH: Secondary prevention of non-fatal deliberate self-harm. The green card study. Br J Psychiatry 1993;163:111-112.
22. Mortensen PB, Agerbo E, Erikson T, Qin P, Westergaard-Nielsen N: Psychiatric illness and risk factors for suicide in Denmark. Lancet 2000;355:9-12.
23. Olfson M, Shaffer D, Marcus SC, Greenberg T: Relationship between antidepressant medication and suicide in adolescents. Arch Gen Psychiatry 2003;60:978-982.
24. Pfennig A, Berghöfer A, Bauer M: Medikamentöse Behandlung der Suizidalität. Verhaltenstherapie 2005 DOI: 10.1159/000083490.
25. Simon GE, Von Korff M, Piccinelli M, Fullerton C, Ormel J: An international study of the relation between somatic symptoms and depression. N Engl J Med 1999;341:1329-1335.
26. Tsuang MT, Woolson RF: Excess mortalità in schizophrenia and affective disorders. - Do suicides and accidental deaths solely account for this excess? Arch Gen Psychiatry 1978;35:1181-1185.
27. WHO (ed): World Health Organisation Info Package: Mastering Depression in Primary Care. Frederiksborg, WHO, 1998.
28. Wittchen H-U, Müller N, Schmidtkunz B, Winter S, Pfister H: Erscheinungsformen, Häufigkeit und Versorgung von Depressionen. Fortschr Med 2000; 118(S1):4-10.
29. Ziegler W, Hegerl U: Der Werthereffekt: Bedeutung, Mechanismen und Konsequenzen. Nervenarzt 2002;73: 41-49.